Interventional Cardiology Devices Market By product type (Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons, Percutaneous Transluminal Coronary, Angioplasty (PTCA) Guide Wires, Stents, Catheters, Inferior Vena Cava (IVC) Filters, Intravascular Ultrasound Systems, Left Atrial Appendage (LAA) Devices and Others), by disease type (Congestive Heart Disease, Percutaneous Valve Replacement, Percutaneous Valve Repair, Coronary Thrombectomy, Others), by end user (Hospitals, Clinics, Cardiac Catheterization Labs, Ambulatory Surgical Centres) and region  

The global interventional cardiology devices market size is expected to reach USD 21.4 billion by 2027 from USD 12.9 billion in 2021, at a CAGR of 8.9% during the forecast period. Interventional cardiology deals with the treatment of various heart diseases by using intravascular catheter-based techniques. Interventional cardiology devices are commonly used in the treatment of coronary artery disease, conventional artery disease, and aneurysm. In this technique, catheter is inserted into any large peripheral artery or vein with the help of fluoroscopy by catheter whole procedure. Interventional cardiology provides controlled bleeding and fast recovery within a short period of time and reduce the complications for patients. The most commonly used interventional cardiology devices include balloon-inflation devices, coronary stents, and cutting balloon catheters among others. Increase in the incidence rate of various cardiovascular diseases, a rise in preference for minimally invasive procedures, growing clinical trials for the novel interventional cardiology devices, and technological advancements of devices are anticipated to fuel the interventional cardiology devices market over the forecast period. Moreover, favourable reimbursement policies for the devices, lifestyle changes, and rise in product launchings might bolster the market. However, stringent regulatory policies, product recall, high cost for the manufacturing of interventional cardiology devices & treatments, and lack of skilled professionals are expected to dampen the market over the forecast period.